AAPG
Ascentage Pharma Group International
NASDAQ: AAPG · HEALTHCARE · BIOTECHNOLOGY
$22.88
+1.76% today
Updated 2026-04-30
Market cap
$2.15B
P/E ratio
—
P/S ratio
3.74x
EPS (TTM)
$-2.04
Dividend yield
—
52W range
$19 – $48
Volume
0.0M
Ascentage Pharma Group International (AAPG) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-45.89M | $-107.98M | $-237.67M | $-460.31M | $-609.96M | $-604.68M | $-653.91M | $-726.08M | $-111.36M |
| Capital expenditures | $3.37M | $20.54M | $49.46M | $81.42M | $251.48M | $436.63M | $236.96M | $56.84M | $24.29M |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $64.99M | — | $27.57M | $70.82M | $74.03M | $46.97M | $22.11M | $31.50M | $20.92M |
| Free cash flow | $-49.26M | $-128.52M | $-287.13M | $-541.72M | $-861.43M | $-1.04B | $-890.88M | $-782.92M | $-135.65M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — |